Long-term HSCs (LT-HSCs) are defined by their ability to give rise to the lymphoid and myeloerythroid lineages for life after transplantation into lethally irradiated recipients. Short-term HSCs (ST-HSCs) have more limited self-renewal capacity and are capable of giving rise to these lineages for 8-12 weeks. The HSC pool has been shown to be heterogeneous in size (1) , cell cycle status (2) , rhodamine staining (3) , and surface molecule expression (4) (5) (6) . Further division of the stem cell pool based on these characteristics has allowed for separation of HSCs, providing long-or short-term engraftment.
The receptor tyrosine kinase Flk-2 has been shown to have heterogeneous expression on the stem cell pool. Long-term reconstituting activity has been demonstrated in both the Flk-2-positive and -negative fractions (7, 8) ; the Flk-2 Ϫ fraction of adult bone marrow (BM) is hypothesized to contain the most primitive HSCs (8) . Flk-2 was cloned initially from a highly purified fetal liver HSC library and shows a high degree of homology to the c-kit and c-fms receptors (9, 10) . Flk-2 stimulated by the flt3 ligand has been implicated as both a survival (11) and a proliferative signal (12) of primitive hematopoietic progenitors, acting in synergy with the receptors for steel factor, IL-6, IL-11, granulocyte colony-stimulating factor, or thrombopoietin in enhancing the expansion of both murine (11, (13) (14) (15) (16) and human (17) (18) (19) (20) primitive progenitors.
To date, Flk-2 receptor expression has been assayed on cells enriched for HSC activity but not on highly purified HSCs. In this study we analyzed the functional differences in cells of HSC phenotype that do or do not express Flk-2. In adult BM, Flk-2 The addition of Flk-2 to the lineage mix allows isolation of highly purified HSCs from many mouse strains using three-color fluorescence-activated cell sorting capability.
Methods
Mouse Strains. The C57BL͞Ka-Thy-1.1 (Thy-1.1, Ly5.1), C57BL͞ Ka-Thy-1.2 (Thy-1.2, Ly5.1), C57BL͞Ka-Ly5.2 (Thy1.2, Ly5.2), and C57BL͞Ka-Thy-1.1͞Ly5.2 (Thy-1.1, Ly5.2) mouse strains were bred and maintained at the Stanford University Laboratory Animal Facility. All mice were maintained routinely on acidified water (pH 2.5). Donors of purified HSCs and progenitors were 6-10 weeks of age. Irradiated recipient mice were greater than 8 weeks old at the time of irradiation.
Antibodies. The monoclonal antibodies used in immunofluorescence staining for HSC and progenitor isolation included 2B8 (anti-c-kit, Allo-phycocyanin), 19XE5 (anti-Thy-1.1, FITC conjugate), E13 (anti-Sca-1, Ly6A͞E, Texas red conjugate), and A2F10 (anti-Flk-2͞Flt3, CD135, phycoerythrin conjugate, Becton Dickenson-PharMingen). Lineage marker antibodies included 6B2 (anti-B220), KT31.1 (anti-CD3), GK1.5 (anti-CD4), 53-7.3 (anti-CD5), 53-6.7 (anti-CD8), Ter119 (anti-erythrocytespecific antigen), 8C5 (anti-Gr-1), and M1͞70 (anti-Mac-1). Unconjugated lineage antibodies were used in conjunction with anti-rat Cy5PE (Caltag, South San Francisco, CA). Directly labeled phycoerythrin and Cy5PE (eBioscience, San Diego, CA) lineage antibodies were sometimes used. Biotinylated 3C11 (anti-c-kit) was used for the enrichment of c-kit ϩ cells; 3C11 and 2B8 recognize distinct, nonoverlapping epitopes of c-kit. A20.1 (anti-Ly5.1, FITC-conjugated, Becton Dickenson-PharMingen), and AL1-4A2 (anti-Ly5.2, Texas red conjugate) were used to analyze donor cells after reconstitution.
Cell Preparation and Staining. Adult KTLS cells were isolated as described (6) . c-kit-positive cells were enriched by positive selection using streptavidin-conjugated magnetic beads and an autoMACS cell separator (Miltenyi Biotec, Auburn, CA) according to manufacturer instructions. Fetal livers were collected at embryonic day 14.5 and dispersed by drawing them several times through a 26-gauge needle. Fetal liver preparations were as described above except Mac-1 was not included in the lineage mixture. Fetal liver cells were depleted of lineage ϩ cells by labeling with purified lineage antibodies followed by sheep anti-rat magnetic beads (Dynal, Great Neck, NY) per manufacturer instructions. All cells used in this study were double-sorted for purity.
Competitive Reconstitution. Recipient mice were lethally irradiated with a split dose of 950 rad as described (6) . Sorted cells were transferred by retroorbital injection along with a radioprotective dose of 3 ϫ 10 5 recipient type whole BM (WBM) cells. For intrathymic injections, 6-week-old congenic recipients were sublethally irradiated with a single dose of 600 rad. Twenty sorted cells were injected directly into a single thymic lobe with 10 5 carrier donor type thymocytes as described (21, 22) .
Methylcellulose Assays. Stem and progenitor cells were sorted at 1 cell per well with an automated cell deposition unit device (Becton Dickenson) into 96-well plates containing Methylcult H4100 (StemCell Technologies, Vancouver) supplemented with FCS and the following cytokines; stem cell factor, Flt-3, IL-6, IL-11, granulocyte͞macrophage colony-stimulating factor, IL-3, human thrombopoietin, and human erythropoietin. The final concentration of growth factors was 10 ng͞ml except for erythropoietin (at 4 units͞ml).
Results

Phenotypic and Functional Heterogeneity of Flk-2 Expression by HSCs.
To determine the level of Flk-2 expression by purified HSCs, we analyzed staining of highly enriched KTLS HSCs with an antiFlk-2 monoclonal antibody by flow cytometry. As shown in Fig.  1 , Flk-2 staining was heterogeneous. To determine whether there were functional differences between Flk-2 ϩ and Flk-2 Ϫ KTLS cells, we double-sorted both populations and tested their long-term repopulating ability in lethally irradiated congenic hosts ( Fig. 1 B and C) . Low numbers of stem cells (20-100) were transferred intravenously along with a radioprotective dose of host-type WBM. Peripheral blood was analyzed periodically for donor lymphoid and myeloid cells. Flk-2 Ϫ KTLS HSCs provided donor-derived long-term multilineage reconstitution in the majority of recipients (Table 1) . Whether 20, 50, or 100 Flk-2 ϩ HSCs were transferred, reconstitution ability was largely transient (Table 1 , Fig. 1B ). In the few individuals that showed long-term repopulation after Flk-2 ϩ HSC reconstitution, the level of reconstitution was very low: Յ1%. These findings indicate that long-term repopulating HSCs are Flk-2 Ϫ , whereas Flk-2 ϩ HSCs are transiently repopulating stem cells with shortterm repopulating ability. (Table 2 ). All mice showed a low level of multilineage donor reconstitution by 6 weeks. However, by 8 weeks most had only donor lymphoid contribution, and by 15 weeks no donor myeloid cells were detectable above background levels in any of the mice.
The Thy-1.1 Ϫ Flk-2 ϩ population yielded similar multilineage reconstitution at low (10) (11) (12) (13) (14) (15) (16) (17) (18) (19) (20) cell numbers (Table 2) , although burst size was small. Because the burst size is minimal from the Thy-1.1 Ϫ Flk-2 ϩ population, recipient mice were killed at 2-3 weeks. Blood and BM were analyzed for the presence of donor B and myeloid cells. We also tested the ability of the Thy-1.1 Ϫ Flk-2 ϩ population to give rise to T cells at low cell numbers (Fig. 2B) . Twenty Thy-1.1 Ϫ Flk-2 ϩ cells were injected intrathymically into sublethally irradiated recipients along with a carrier population of host-type thymocytes. Thymuses were analyzed at 3 weeks. In all injected mice, the thymus was populated with donor-type thymocytes (both double-and single-positive for CD4 and CD8) in a pattern indicating normal T cell development from Thy-1. (Fig. 3B) the Thy-1.1 Ϫ subset was Analysis of competitive repopulation by Flk-2 ϩ or Flk-2 Ϫ HSCs. The donor repopulation profiles are given as a percentage of transplanted mice. The presence of donor B, T, and myeloid cells lasting longer than 16 weeks are designated long-term BϩTϩM. Transient BϩTϩM indicates recipients that lost myeloid contribution by 10 -12 weeks. BϩT, BϩM, and B indicate recipients with donor contribution only to the lineages indicated. None indicates no donor cells were detectable above background levels. The frequency of repopulation is the total donor white blood cell count divided by the total live cell count of a given blood sample. (Fig. 3C) . The donor reconstitution profiles were indistinguishable between these two sorting protocols.
We also sorted Flk-2
Ϫ
HSCs from C57BL͞Ka (Thy1.2) mice, which do not express the Thy-1.1 allele. Congenic recipients were transplanted as described above. Long-term reconstitution evi- Several phenotypic and functional differences have been observed between adult BM and fetal liver HSCs. Because the flk-2 cDNA was isolated originally from primitive fetal HSCs, we wished to determine the characteristics of Flk-2 expression on the fetal liver HSC population. The c-kit (Table 3 ). Similar to that in the adult BM, no long-term activity was found to be present in the Thy-1. (Fig. 2 A) . As described previously the Thy-1.1 lo portion contains all the long-term reconstitution activity of adult BM (6, 26, 27) . The Thy-1. 
Flk-2
ϩ population has any detectable self-renewal potential; its limited temporal production of myeloid cells in vivo rules out longer term self-renewal. Thus, as BM HSCs mature and begin to differentiate, Thy-1.1 is downregulated and Flk-2 is up-regulated. Interestedly, Flk-2 expression is maintained by the down-stream oligopotent progenitors, the common lymphoid progenitor, and common myeloid progenitor (M. Manz, unpublished results). We propose that Flk-2 is an important negative indicator of BM stem cell self-renewal capacity, becomes up-regulated as stem cells become more mature, and may be important in expanding primitive cell types. The use of Flt3 ligand as an in vitro expansion factor of HSCs has been explored in several reports (14, 16) . Because Flk-2 is not expressed by LT-HSCs, any measured expansion may be indirect or an expansion of progenitors down-stream of the LT-HSC.
Simplified LT-HSC Sorting. HSCs have been enriched by several means (1, 3, (26) (27) (28) (29) (30) (31) (32) (33) (34) (35) . Further purification and isolation of highly enriched populations of HSCs have been achieved by using cell surface antibody staining and fluorescence-activated cell sorting (6, 36) . We have shown that Flk-2 can replace Thy-1.1 for purifying LT-HSCs from lines of mice that do not express Thy-1.1. This strategy allows for LT-HSC isolation with only three color-sorting parameters, which opens up additional parameters for analysis of other potential markers on the LT-HSC population. This finding will allow for the analysis of stem cell activity in knockout or transgenic lines, which usually are in backgrounds without Thy-1.1 expression. Also, many currently used mouse models are not on a Thy-1.1 background. Phenotypically, the fetal liver HSCs express the cell surface markers Mac-1 and AA4.1, which are not expressed on the long-term repopulating HSCs in adult BM (37, 38) . Fetal liver HSCs cycle more rapidly and give a more robust reconstitution than adult HSCs (37) (38) (39) (40) . Most of the stem cell pool of adult HSCs is composed of short-term and multipotent progenitors, whereas most stem cells in the fetal liver are thought to be LT-HSCs (41) . Several lineages of specialized lymphoid cells arise during fetal hematopoiesis derived from fetal HSCs that cannot be generated by adult BM HSCs (42) (43) (44) .
Long-Term Activity Is Found in both the
The Flk-2 expression pattern on the HSC pool allows further definition of the HSC population. Expression of the Flk-2 Analysis of competitive reconstitution by Flk-2 ϩ and Flk-2 Ϫ fetal liver HSCs as described in the Table 1 legend.
